ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Depression Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: May 2025
|
Report Code: QYRE-Auto-7231
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Depression Drugs Market Size Status and Forecast 2022
BUY CHAPTERS

Global Depression Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-7231
Report
May 2025
Pages:142
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Intellipharmaceutics
Pfizer Inc
Eli Lilly
Astrazeneca plc
Lundbeck
Otsuka Pharmaceutical
Takeda
NHU Group
Shionogi
Apotex
Kanghong Pharma
HUAHAI
Allergan plc
GSK

Depression Drugs Market Size

In 2024, the global market size of Depression Drugs was estimated to be worth US$ 18130 million and is forecast to reach approximately US$ 22080 million by 2031 with a CAGR of 2.9% during the forecast period 2025-2031.

Depression Drugs Market

Depression Drugs Market

Depression is a mental health issue. It’s a condition that starts most often in early adulthood. It’s also more common in women. However, anyone at any age may suffer from depression. Depression affects the brain, so drugs that work in the brain may offer hope. Common antidepressants may help ease your symptoms, but there are many other options as well. Each drug used to treat depression works by balancing certain chemicals in your brain called neurotransmitters. Depression Drugs is drugs used for Depression.
Global Depression Drugs key players include Intellipharmaceutics, Pfizer, Eli Lilly, Astrazeneca, Lundbeck, etc. Global top five manufacturers hold a share over 35%.
North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share about 50%.
In terms of product, SSRIs is the largest segment, with a share over 45%. And in terms of application, the largest application is Hospitals, followed by Clinics, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Depression Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Depression Drugs.
The Depression Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Depression Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Depression Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Depression Drugs Market Report

Report Metric Details
Report Name Depression Drugs Market
Forecasted market size in 2031 approximately US$ 22080 million
CAGR 2.9%
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Intellipharmaceutics, Pfizer, Eli Lilly, Astrazeneca, Lundbeck, Allergan, GSK, Otsuka Pharmaceutical, Takeda, NHU Group, Shionogi, APOTEX, Kanghong Pharma, HUAHAI
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Depression Drugs in global and regional level.
  • Chapter 3: Detailed analysis of Depression Drugs company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Depression Drugs revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Depression Drugs Market size in 2031?

Ans: The Depression Drugs Market size in 2031 will be approximately US$ 22080 million.

What is the market share of major companies in Depression Drugs Market?

Ans: Global top five manufacturers hold a share over 35%.

What is the Depression Drugs Market share by type?

Ans: In terms of product, SSRIs is the largest segment, with a share over 45%.

Who are the main players in the Depression Drugs Market report?

Ans: The main players in the Depression Drugs Market are Intellipharmaceutics, Pfizer, Eli Lilly, Astrazeneca, Lundbeck, Allergan, GSK, Otsuka Pharmaceutical, Takeda, NHU Group, Shionogi, APOTEX, Kanghong Pharma, HUAHAI

What are the Application segmentation covered in the Depression Drugs Market report?

Ans: The Applications covered in the Depression Drugs Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Depression Drugs Market report?

Ans: The Types covered in the Depression Drugs Market report are SSRIs, SNRIs, Others

Recommended Reports

CNS Disorder Drugs

Alzheimer & Parkinson Drugs

Psychiatric & Mood Treatments

Market trends :

Topic Trends
Global the depression drugs market is experiencing steady growth driven by increasing awareness of mental health, rising prevalence of depression, and ongoing product innovation in ssris and snris.
Type SSRIs - ssris remain the leading segment in depression drugs due to their established efficacy and widespread adoption in clinical practice.
SNRIs - snris are gaining traction as alternative therapies for patients unresponsive to ssris, supporting incremental market growth.
Application Hospitals - hospitals continue to be the primary channel for depression drug prescriptions, reflecting their role in acute and severe depression management.
Clinics - clinics are expanding their role in depression treatment as outpatient care and mental health services become more accessible.
Region North America - north america maintains the largest market share for depression drugs, supported by high diagnosis rates and advanced healthcare infrastructure.
EMEA - emea region sees steady demand for depression drugs, with increasing focus on mental health policies and access to innovative therapies.
APAC - apac is witnessing rising demand for depression drugs due to growing mental health awareness and expanding healthcare coverage.
LATAM - latam shows moderate growth in depression drug adoption, driven by improving healthcare access and mental health initiatives.
1 Study Coverage
1.1 Depression Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Depression Drugs Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 SSRIs
1.2.3 SNRIs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Depression Drugs Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Depression Drugs Market Size Estimates and Forecasts
2.2 Depression Drugs Market Size by Region: 2024 Versus 2031
2.2.1 Global Depression Drugs Revenue by Region: 2020-2025
2.2.2 Global Depression Drugs Revenue Forecast by Region (2026-2031)
2.2.3 Global Depression Drugs Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Depression Drugs Revenue by Type (2020-2031)
3.1.2 Global Depression Drugs Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Depression Drugs Revenue by Application (2020-2031)
3.2.2 Global Depression Drugs Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 SSRIs of Depression Drugs Revenue Market Share by Application
3.3.2 SNRIs of Depression Drugs Revenue Market Share by Application
3.3.3 Others of Depression Drugs Revenue Market Share by Application
4 Global Depression Drugs by Company
4.1 Global Depression Drugs Revenue by Company (2020-2025)
4.2 Global Depression Drugs Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Depression Drugs Companies around the World: Ranking by Revenue
4.3.2 Global Depression Drugs Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Depression Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Depression Drugs Companies Headquarters & Product Type
4.4.1 Global Depression Drugs Companies Headquarters
4.4.2 Date of International Companies Enter into Depression Drugs Market
4.4.3 Global Depression Drugs Companies Product & Service
4.4.4 SSRIs Revenue Market Share of Depression Drugs by Company
4.4.5 SNRIs Revenue Market Share of Depression Drugs by Company
4.4.6 Others Revenue Market Share of Depression Drugs by Company
4.5 Global Depression Drugs Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Intellipharmaceutics
5.1.1 Intellipharmaceutics Corporation Information
5.1.2 Intellipharmaceutics Description, Business Overview
5.1.3 Intellipharmaceutics Depression Drugs Products Offered
5.1.4 Intellipharmaceutics Depression Drugs Revenue and Gross Margin (2020-2025)
5.1.5 Intellipharmaceutics Depression Drugs Revenue by Product in 2024
5.1.6 Intellipharmaceutics Depression Drugs Revenue by Application in 2024
5.1.7 Intellipharmaceutics Depression Drugs Revenue by Geographic Area in 2024
5.1.8 Intellipharmaceutics Recent Developments
5.2 Pfizer
5.2.1 Pfizer Corporation Information
5.2.2 Pfizer Description, Business Overview
5.2.3 Pfizer Depression Drugs Products Offered
5.2.4 Pfizer Depression Drugs Revenue and Gross Margin (2020-2025)
5.2.5 Pfizer Depression Drugs Revenue by Product in 2024
5.2.6 Pfizer Depression Drugs Revenue by Application in 2024
5.2.7 Pfizer Depression Drugs Revenue by Geographic Area in 2024
5.2.8 Pfizer Recent Developments
5.3 Eli Lilly
5.3.1 Eli Lilly Corporation Information
5.3.2 Eli Lilly Description, Business Overview
5.3.3 Eli Lilly Depression Drugs Products Offered
5.3.4 Eli Lilly Depression Drugs Revenue and Gross Margin (2020-2025)
5.3.5 Eli Lilly Depression Drugs Revenue by Product in 2024
5.3.6 Eli Lilly Depression Drugs Revenue by Application in 2024
5.3.7 Eli Lilly Depression Drugs Revenue by Geographic Area in 2024
5.3.8 Eli Lilly Recent Developments
5.4 Astrazeneca
5.4.1 Astrazeneca Corporation Information
5.4.2 Astrazeneca Description, Business Overview
5.4.3 Astrazeneca Depression Drugs Products Offered
5.4.4 Astrazeneca Depression Drugs Revenue and Gross Margin (2020-2025)
5.4.5 Astrazeneca Depression Drugs Revenue by Product in 2024
5.4.6 Astrazeneca Depression Drugs Revenue by Application in 2024
5.4.7 Astrazeneca Depression Drugs Revenue by Geographic Area in 2024
5.4.8 Astrazeneca Recent Developments
5.5 Lundbeck
5.5.1 Lundbeck Corporation Information
5.5.2 Lundbeck Description, Business Overview
5.5.3 Lundbeck Depression Drugs Products Offered
5.5.4 Lundbeck Depression Drugs Revenue and Gross Margin (2020-2025)
5.5.5 Lundbeck Depression Drugs Revenue by Product in 2024
5.5.6 Lundbeck Depression Drugs Revenue by Application in 2024
5.5.7 Lundbeck Depression Drugs Revenue by Geographic Area in 2024
5.5.8 Lundbeck Recent Developments
5.6 Allergan
5.6.1 Allergan Corporation Information
5.6.2 Allergan Description, Business Overview
5.6.3 Allergan Depression Drugs Products Offered
5.6.4 Allergan Depression Drugs Revenue and Gross Margin (2020-2025)
5.6.5 Allergan Depression Drugs Revenue by Product in 2024
5.6.6 Allergan Depression Drugs Revenue by Application in 2024
5.6.7 Allergan Depression Drugs Revenue by Geographic Area in 2024
5.6.8 Allergan Recent Developments
5.7 GSK
5.7.1 GSK Corporation Information
5.7.2 GSK Description, Business Overview
5.7.3 GSK Depression Drugs Products Offered
5.7.4 GSK Depression Drugs Revenue and Gross Margin (2020-2025)
5.7.5 GSK Depression Drugs Revenue by Product in 2024
5.7.6 GSK Depression Drugs Revenue by Application in 2024
5.7.7 GSK Depression Drugs Revenue by Geographic Area in 2024
5.7.8 GSK Recent Developments
5.8 Otsuka Pharmaceutical
5.8.1 Otsuka Pharmaceutical Corporation Information
5.8.2 Otsuka Pharmaceutical Description, Business Overview
5.8.3 Otsuka Pharmaceutical Depression Drugs Products Offered
5.8.4 Otsuka Pharmaceutical Depression Drugs Revenue and Gross Margin (2020-2025)
5.8.5 Otsuka Pharmaceutical Depression Drugs Revenue by Product in 2024
5.8.6 Otsuka Pharmaceutical Depression Drugs Revenue by Application in 2024
5.8.7 Otsuka Pharmaceutical Depression Drugs Revenue by Geographic Area in 2024
5.8.8 Otsuka Pharmaceutical Recent Developments
5.9 Takeda
5.9.1 Takeda Corporation Information
5.9.2 Takeda Description, Business Overview
5.9.3 Takeda Depression Drugs Products Offered
5.9.4 Takeda Depression Drugs Revenue and Gross Margin (2020-2025)
5.9.5 Takeda Depression Drugs Revenue by Product in 2024
5.9.6 Takeda Depression Drugs Revenue by Application in 2024
5.9.7 Takeda Depression Drugs Revenue by Geographic Area in 2024
5.9.8 Takeda Recent Developments
5.10 NHU Group
5.10.1 NHU Group Corporation Information
5.10.2 NHU Group Description, Business Overview
5.10.3 NHU Group Depression Drugs Products Offered
5.10.4 NHU Group Depression Drugs Revenue and Gross Margin (2020-2025)
5.10.5 NHU Group Depression Drugs Revenue by Product in 2024
5.10.6 NHU Group Depression Drugs Revenue by Application in 2024
5.10.7 NHU Group Depression Drugs Revenue by Geographic Area in 2024
5.10.8 NHU Group Recent Developments
5.11 Shionogi
5.11.1 Shionogi Corporation Information
5.11.2 Shionogi Description, Business Overview
5.11.3 Shionogi Depression Drugs Products Offered
5.11.4 Shionogi Depression Drugs Revenue and Gross Margin (2020-2025)
5.11.5 Shionogi Depression Drugs Revenue by Product in 2024
5.11.6 Shionogi Depression Drugs Revenue by Application in 2024
5.11.7 Shionogi Depression Drugs Revenue by Geographic Area in 2024
5.11.8 Shionogi Recent Developments
5.12 APOTEX
5.12.1 APOTEX Corporation Information
5.12.2 APOTEX Description, Business Overview
5.12.3 APOTEX Depression Drugs Products Offered
5.12.4 APOTEX Depression Drugs Revenue and Gross Margin (2020-2025)
5.12.5 APOTEX Depression Drugs Revenue by Product in 2024
5.12.6 APOTEX Depression Drugs Revenue by Application in 2024
5.12.7 APOTEX Depression Drugs Revenue by Geographic Area in 2024
5.12.8 APOTEX Recent Developments
5.13 Kanghong Pharma
5.13.1 Kanghong Pharma Corporation Information
5.13.2 Kanghong Pharma Description, Business Overview
5.13.3 Kanghong Pharma Depression Drugs Products Offered
5.13.4 Kanghong Pharma Depression Drugs Revenue and Gross Margin (2020-2025)
5.13.5 Kanghong Pharma Depression Drugs Revenue by Product in 2024
5.13.6 Kanghong Pharma Depression Drugs Revenue by Application in 2024
5.13.7 Kanghong Pharma Depression Drugs Revenue by Geographic Area in 2024
5.13.8 Kanghong Pharma Recent Developments
5.14 HUAHAI
5.14.1 HUAHAI Corporation Information
5.14.2 HUAHAI Description, Business Overview
5.14.3 HUAHAI Depression Drugs Products Offered
5.14.4 HUAHAI Depression Drugs Revenue and Gross Margin (2020-2025)
5.14.5 HUAHAI Depression Drugs Revenue by Product in 2024
5.14.6 HUAHAI Depression Drugs Revenue by Application in 2024
5.14.7 HUAHAI Depression Drugs Revenue by Geographic Area in 2024
5.14.8 HUAHAI Recent Developments
6 North America
6.1 North America Depression Drugs Market Size YoY Growth 2020-2031
6.2 North America Depression Drugs Market Facts & Figures by Country (2020-2031)
6.3 North America Depression Drugs Revenue by Type (2020-2025)
6.4 North America Depression Drugs Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Depression Drugs Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Depression Drugs Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Depression Drugs Revenue by Type (2020-2025)
7.4 Asia-Pacific Depression Drugs Revenue by Application (2020-2025)
8 Europe
8.1 Europe Depression Drugs Market Size YoY Growth 2020-2031
8.2 Europe Depression Drugs Market Facts & Figures by Country (2020-2031)
8.3 Europe Depression Drugs Revenue by Type (2020-2025)
8.4 Europe Depression Drugs Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Depression Drugs Market Size YoY Growth 2020-2031
9.2 Latin America Depression Drugs Market Facts & Figures by Country (2020-2031)
9.3 Latin America Depression Drugs Revenue by Type (2020-2025)
9.4 Latin America Depression Drugs Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Depression Drugs Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Depression Drugs Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Depression Drugs Revenue by Type (2020-2025)
10.4 Middle East and Africa Depression Drugs Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Depression Drugs Supply Chain Analysis
11.2 Depression Drugs Key Raw Materials and Upstream Suppliers
11.3 Depression Drugs Clients Analysis
11.4 Depression Drugs Sales Channel and Sales Model Analysis
11.4.1 Depression Drugs Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Depression Drugs Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Depression Drugs Distributors
12 Depression Drugs Market Dynamics
12.1 Depression Drugs Industry Trends
12.2 Depression Drugs Market Drivers
12.3 Depression Drugs Market Challenges
12.4 Depression Drugs Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Intellipharmaceutics
Pfizer Inc
Eli Lilly
Astrazeneca plc
Lundbeck
Otsuka Pharmaceutical
Takeda
NHU Group
Shionogi
Apotex
Kanghong Pharma
HUAHAI
Allergan plc
GSK
List of Tables
 Table 1. Global Depression Drugs Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Depression Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Depression Drugs Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Depression Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Depression Drugs Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Depression Drugs Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Depression Drugs Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Depression Drugs Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Depression Drugs Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Depression Drugs Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Depression Drugs Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Depression Drugs Players by Revenue (US$ Million) in 2024
 Table 13. Global Depression Drugs Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Depression Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Depression Drugs as of 2024)
 Table 15. Global Depression Drugs Companies Headquarters
 Table 16. Date of International Companies Enter into Depression Drugs Market
 Table 17. Global Depression Drugs Companies Product & Service
 Table 18. Global Depression Drugs Mergers & Acquisitions, Expansion Plans
 Table 19. Intellipharmaceutics Corporation Information
 Table 20. Intellipharmaceutics Description and Business Overview
 Table 21. Intellipharmaceutics Depression Drugs Product
 Table 22. Intellipharmaceutics Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. Intellipharmaceutics Revenue Proportion of Depression Drugs by Product in 2024
 Table 24. Intellipharmaceutics Revenue Proportion of Depression Drugs by Application in 2024
 Table 25. Intellipharmaceutics Revenue Proportion of Depression Drugs by Geographic Area in 2024
 Table 26. Intellipharmaceutics Recent Developments
 Table 27. Pfizer Corporation Information
 Table 28. Pfizer Description and Business Overview
 Table 29. Pfizer Depression Drugs Product
 Table 30. Pfizer Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. Pfizer Revenue Proportion of Depression Drugs by Product in 2024
 Table 32. Pfizer Revenue Proportion of Depression Drugs by Application in 2024
 Table 33. Pfizer Revenue Proportion of Depression Drugs by Geographic Area in 2024
 Table 34. Pfizer Recent Developments
 Table 35. Eli Lilly Corporation Information
 Table 36. Eli Lilly Description and Business Overview
 Table 37. Eli Lilly Depression Drugs Product
 Table 38. Eli Lilly Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. Eli Lilly Revenue Proportion of Depression Drugs by Product in 2024
 Table 40. Eli Lilly Revenue Proportion of Depression Drugs by Application in 2024
 Table 41. Eli Lilly Revenue Proportion of Depression Drugs by Geographic Area in 2024
 Table 42. Eli Lilly Recent Developments
 Table 43. Astrazeneca Corporation Information
 Table 44. Astrazeneca Description and Business Overview
 Table 45. Astrazeneca Depression Drugs Product
 Table 46. Astrazeneca Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Astrazeneca Revenue Proportion of Depression Drugs by Product in 2024
 Table 48. Astrazeneca Revenue Proportion of Depression Drugs by Application in 2024
 Table 49. Astrazeneca Revenue Proportion of Depression Drugs by Geographic Area in 2024
 Table 50. Astrazeneca Recent Developments
 Table 51. Lundbeck Corporation Information
 Table 52. Lundbeck Description and Business Overview
 Table 53. Lundbeck Depression Drugs Product
 Table 54. Lundbeck Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. Lundbeck Revenue Proportion of Depression Drugs by Product in 2024
 Table 56. Lundbeck Revenue Proportion of Depression Drugs by Application in 2024
 Table 57. Lundbeck Revenue Proportion of Depression Drugs by Geographic Area in 2024
 Table 58. Lundbeck Recent Developments
 Table 59. Allergan Corporation Information
 Table 60. Allergan Description and Business Overview
 Table 61. Allergan Depression Drugs Product
 Table 62. Allergan Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. Allergan Revenue Proportion of Depression Drugs by Product in 2024
 Table 64. Allergan Revenue Proportion of Depression Drugs by Application in 2024
 Table 65. Allergan Revenue Proportion of Depression Drugs by Geographic Area in 2024
 Table 66. Allergan Recent Developments
 Table 67. GSK Corporation Information
 Table 68. GSK Description and Business Overview
 Table 69. GSK Depression Drugs Product
 Table 70. GSK Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. GSK Revenue Proportion of Depression Drugs by Product in 2024
 Table 72. GSK Revenue Proportion of Depression Drugs by Application in 2024
 Table 73. GSK Revenue Proportion of Depression Drugs by Geographic Area in 2024
 Table 74. GSK Recent Developments
 Table 75. Otsuka Pharmaceutical Corporation Information
 Table 76. Otsuka Pharmaceutical Description and Business Overview
 Table 77. Otsuka Pharmaceutical Depression Drugs Product
 Table 78. Otsuka Pharmaceutical Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 79. Otsuka Pharmaceutical Revenue Proportion of Depression Drugs by Product in 2024
 Table 80. Otsuka Pharmaceutical Revenue Proportion of Depression Drugs by Application in 2024
 Table 81. Otsuka Pharmaceutical Revenue Proportion of Depression Drugs by Geographic Area in 2024
 Table 82. Otsuka Pharmaceutical Recent Developments
 Table 83. Takeda Corporation Information
 Table 84. Takeda Description and Business Overview
 Table 85. Takeda Depression Drugs Product
 Table 86. Takeda Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 87. Takeda Revenue Proportion of Depression Drugs by Product in 2024
 Table 88. Takeda Revenue Proportion of Depression Drugs by Application in 2024
 Table 89. Takeda Revenue Proportion of Depression Drugs by Geographic Area in 2024
 Table 90. Takeda Recent Developments
 Table 91. NHU Group Corporation Information
 Table 92. NHU Group Description and Business Overview
 Table 93. NHU Group Depression Drugs Product
 Table 94. NHU Group Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 95. NHU Group Revenue Proportion of Depression Drugs by Product in 2024
 Table 96. NHU Group Revenue Proportion of Depression Drugs by Application in 2024
 Table 97. NHU Group Revenue Proportion of Depression Drugs by Geographic Area in 2024
 Table 98. NHU Group Recent Developments
 Table 99. Shionogi Corporation Information
 Table 100. Shionogi Description and Business Overview
 Table 101. Shionogi Depression Drugs Product
 Table 102. Shionogi Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Shionogi Revenue Proportion of Depression Drugs by Product in 2024
 Table 104. Shionogi Revenue Proportion of Depression Drugs by Application in 2024
 Table 105. Shionogi Revenue Proportion of Depression Drugs by Geographic Area in 2024
 Table 106. Shionogi Recent Developments
 Table 107. APOTEX Corporation Information
 Table 108. APOTEX Description and Business Overview
 Table 109. APOTEX Depression Drugs Product
 Table 110. APOTEX Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 111. APOTEX Revenue Proportion of Depression Drugs by Product in 2024
 Table 112. APOTEX Revenue Proportion of Depression Drugs by Application in 2024
 Table 113. APOTEX Revenue Proportion of Depression Drugs by Geographic Area in 2024
 Table 114. APOTEX Recent Developments
 Table 115. Kanghong Pharma Corporation Information
 Table 116. Kanghong Pharma Description and Business Overview
 Table 117. Kanghong Pharma Depression Drugs Product
 Table 118. Kanghong Pharma Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 119. Kanghong Pharma Revenue Proportion of Depression Drugs by Product in 2024
 Table 120. Kanghong Pharma Revenue Proportion of Depression Drugs by Application in 2024
 Table 121. Kanghong Pharma Revenue Proportion of Depression Drugs by Geographic Area in 2024
 Table 122. Kanghong Pharma Recent Developments
 Table 123. HUAHAI Corporation Information
 Table 124. HUAHAI Description and Business Overview
 Table 125. HUAHAI Depression Drugs Product
 Table 126. HUAHAI Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 127. HUAHAI Revenue Proportion of Depression Drugs by Product in 2024
 Table 128. HUAHAI Revenue Proportion of Depression Drugs by Application in 2024
 Table 129. HUAHAI Revenue Proportion of Depression Drugs by Geographic Area in 2024
 Table 130. HUAHAI Recent Developments
 Table 131. North America Depression Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 132. North America Depression Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 133. North America Depression Drugs Revenue by Type (2020-2025) & (US$ Million)
 Table 134. North America Depression Drugs Revenue by Application (2020-2025) & (US$ Million)
 Table 135. Asia-Pacific Depression Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 136. Asia-Pacific Depression Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 137. Asia-Pacific Depression Drugs Revenue by Type (2020-2025) & (US$ Million)
 Table 138. Asia-Pacific Depression Drugs Revenue by Application (2020-2025) & (US$ Million)
 Table 139. Europe Depression Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 140. Europe Depression Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 141. Europe Depression Drugs Revenue by Type (2020-2025) & (US$ Million)
 Table 142. Europe Depression Drugs Revenue by Application (2020-2025) & (US$ Million)
 Table 143. Latin America Depression Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 144. Latin America Depression Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 145. Latin America Depression Drugs Revenue by Type (2020-2025) & (US$ Million)
 Table 146. Latin America Depression Drugs Revenue by Application (2020-2025) & (US$ Million)
 Table 147. Middle East and Africa Depression Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 148. Middle East and Africa Depression Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 149. Middle East and Africa Depression Drugs Revenue by Type (2020-2025) & (US$ Million)
 Table 150. Middle East and Africa Depression Drugs Revenue by Application (2020-2025) & (US$ Million)
 Table 151. Depression Drugs Key Raw Materials, Industry Status and Trend
 Table 152. Depression Drugs Key Raw Materials and Upstream Suppliers
 Table 153. Depression Drugs Clients Status and Trend
 Table 154. Depression Drugs Typical Clients
 Table 155. Depression Drugs Distributors
 Table 156. Depression Drugs Market Trends
 Table 157. Depression Drugs Market Drivers
 Table 158. Depression Drugs Market Challenges
 Table 159. Depression Drugs Market Restraints
 Table 160. Research Programs/Design for This Report
 Table 161. Key Data Information from Secondary Sources
 Table 162. Key Data Information from Primary Sources


List of Figures
 Figure 1. Depression Drugs Product Picture
 Figure 2. Global Depression Drugs Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Depression Drugs Revenue Market Share by Type in 2024 & 2031
 Figure 4. SSRIs Product Picture
 Figure 5. SNRIs Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Depression Drugs Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 8. Global Depression Drugs Revenue Market Share by Application in 2024 & 2031
 Figure 9. Hospitals
 Figure 10. Clinics
 Figure 11. Others
 Figure 12. Depression Drugs Report Years Considered
 Figure 13. Global Depression Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Depression Drugs Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Depression Drugs Market Size Market Share by Region: 2024 Versus 2031
 Figure 16. Global Depression Drugs Revenue Market Share by Region (2020-2031)
 Figure 17. Global Depression Drugs Revenue Market Share Forecast by Type (2020-2031)
 Figure 18. Global Depression Drugs Revenue Market Share Forecast by Application (2020-2031)
 Figure 19. SSRIs of Depression Drugs Revenue Market Share by Application, 2024 VS 2031
 Figure 20. SNRIs of Depression Drugs Revenue Market Share by Application, 2024 VS 2031
 Figure 21. Others of Depression Drugs Revenue Market Share by Application, 2024 VS 2031
 Figure 22. Depression Drugs Revenue Share by Company (2024)
 Figure 23. Depression Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. SSRIs Revenue Proportion by Company in 2024
 Figure 25. SNRIs Revenue Proportion by Company in 2024
 Figure 26. Others Revenue Proportion by Company in 2024
 Figure 27. North America Depression Drugs Revenue 2020-2031 (US$ Million)
 Figure 28. North America Depression Drugs Revenue Market Share by Type (2020-2025)
 Figure 29. North America Depression Drugs Revenue Market Share by Application (2020-2025)
 Figure 30. Asia-Pacific Depression Drugs Revenue 2020-2031 (US$ Million)
 Figure 31. Asia-Pacific Depression Drugs Revenue Market Share by Region (2020-2031)
 Figure 32. Asia-Pacific Depression Drugs Revenue Market Share by Type (2020-2025)
 Figure 33. Asia-Pacific Depression Drugs Revenue Market Share by Application (2020-2025)
 Figure 34. Europe Depression Drugs Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 35. Europe Depression Drugs Revenue Market Share by Country (2020-2031)
 Figure 36. Europe Depression Drugs Revenue Market Share by Type (2020-2025)
 Figure 37. Europe Depression Drugs Revenue Market Share by Application (2020-2025)
 Figure 38. Latin America Depression Drugs Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 39. Latin America Depression Drugs Revenue Market Share by Country (2020-2031)
 Figure 40. Latin America Depression Drugs Revenue Market Share by Type (2020-2025)
 Figure 41. Latin America Depression Drugs Revenue Market Share by Application (2020-2025)
 Figure 42. Middle East and Africa Depression Drugs Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 43. Middle East and Africa Depression Drugs Revenue Market Share by Country (2020-2031)
 Figure 44. Middle East and Africa Depression Drugs Revenue Market Share by Type (2020-2025)
 Figure 45. Middle East and Africa Depression Drugs Revenue Market Share by Application (2020-2025)
 Figure 46. Depression Drugs Supply Chain (Upstream and Downstream Market)
 Figure 47. Global Production Market Share of Depression Drugs Raw Materials by Region in 2024
 Figure 48. Depression Drugs Distribution Channels
 Figure 49. Global Depression Drugs Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 50. Global Depression Drugs Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 51. Bottom-up and Top-down Approaches for This Report
 Figure 52. Data Triangulation
 Figure 53. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Anti depressant Drugs Market
Anti Depression Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Depression Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antidepressants Drugs Market Insights Forecast to 2030
Global Mental Health Medications Market Research Report 2025
Global SNRIs Antidepressants Market Research Report 2024
Treatment Resistant Depression Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Selective Serotonin Reuptake Inhibitors SSRIs Market Insights Forecast to 2030
Global Psychiatric and Nervous Drugs Market Research Report 2025
Global Sertraline Market Insights Forecast to 2030
Global Major Depressive Disorder Drug Market Research Report 2025
Depression Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anxiety Disorder and Depression Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Suicide Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Treatment Resistant Depression Market Insights Forecast to 2030
Depression Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Mental Disorder Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Psychiatric Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Depression MDD Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antidepressant Medication Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions